Adbelizumab Combined With Chemotherapy for Neoadjuvant Therapy in Resectable Pancreatic Cancer
Conditions: Pancreatic Cancer; Neoadjuvant Therapy Interventions: Drug: Adbelimumab; Drug: albumin-bound paclitaxel; Drug: Gemcitabine Sponsors: Jinling Hospital, China; Jiangsu Hengrui Pharmaceutical Co., Ltd. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Abraxane | Cancer | Cancer & Oncology | Chemotherapy | China Health | Hospitals | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy | Pancreas | Pancreatic Cancer | Research